Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 48653 results
Impax introduces Renvela for patients with chronic kidney disease
By PBR Staff Writer
Impax Laboratories has started shipment of authorized generic Renvela (sevelamer carbonate 800mg tablets), through its generics division Global Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
Islet Sciences reports results from two Phase IIb clinical studies for type 2 diabetics drug
By PBR Staff Writer
Islet Sciences and BHV Pharma have reported positive data from the two 12-week Phase IIb clinical studies of SGLT2 inhibitor remogliflozin etabonate in type 2 diabetics.
Drug Research > Drug Discovery & Development > News
Kyowa Hakko begins Phase III trial of asthma drug benralizumab in Japan
By PBR Staff Writer
Japan-based Kyowa Hakko Kirin has started a Calima, one of several trials in the Phase III program for benralizumab, and also plans to initiate Sirocco, another Phase III trial in South Korea.
Contract Research & Services > Clinical Trials > News
OxThera secures $10m investment to continue clinical programs
By PBR Staff Writer
Swedish biopharmaceutical firm OxThera has received SEK70m ($10m) from a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, to continue its major clinical programs.
Drug Research > Drug Discovery & Development > News
Astellas, MSD launch Suglat tablets in Japan to treat type 2 diabetes
By PBR Staff Writer
Japanese pharmaceutical firm Astellas Pharma and MSD K.K., a subsidiary of Merck, have introduced the selective SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Suglat tablets 25mg and 50mg in Japan for the treatment of type 2 diabetes.
Production & Manufacturing > Manufacturing > News
Iconic Therapeutics raises $20m to advance clinical development of wet AMD program
Iconic Therapeutics has announced that it has successfully completed a $20m Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.
Drug Research > Drug Discovery & Development > News
Apricus Biosciences' UK partner accepts first shipment of Vitaros
Apricus Biosciences has announced that Takeda Pharmaceuticals International, the company's partner in the UK, has accepted the first shipment of Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction (ED).
Production & Manufacturing > Manufacturing > News
Astellas Pharma reaches agreement with US Department of Justice
Astellas Pharma US has reached an agreement with the US Department of Justice to resolve civil claims regarding the marketing of Mycamine (micafungin sodium) for injection.
Drug Research > Drug Delivery > News
European Medicines Agency alerts EU healthcare professionals after vials of falsified Herceptin identified
The European Medicines Agency (EMA) has been informed that vials of the cancer medicine Herceptin (trastuzumab), thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries.
Drug Research > Drug Delivery > News
AMRI realigns discovery and development services to support customer demand
Albany Molecular Research (AMRI) has announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, New York site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014.
Contract Research & Services > Contract Services > News
Dicerna begins Phase I trial of DCR-MYC to treat solid tumors, hematological malignancies
By PBR Staff Writer
US-based biopharmaceutical firm Dicerna Pharmaceuticals has started a Phase I dose-escalating clinical trial of its drug candidate DCR-MYC, (also known as DCR-M1711), in patients with solid tumors, multiple myeloma, or lymphoma.
Drug Research > Drug Delivery > News
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.
Drug Research > Drug Delivery > Suppliers
DesignMedix gets $3m NIH grant to develop low-cost malaria drug
By PBR Staff Writer
US-based biotech startup DesignMedix has received a grant of $3m from the National Institutes of Health (NIH) to continue the development and manufacturing of a new anti-malarial drug.
Drug Research > Drug Discovery & Development > News
Prestige to acquire OTC oral rehydration product Hydralyte in Australia
By PBR Staff Writer
US-based Prestige Brands Holdings has signed an agreement to buy Hydralyte in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia.
Production & Manufacturing > OTC > News
RainTree launches new cloud-based analytics portal for pharmaceutical industry
By PBR Staff Writer
RainTree Oncology Services and Information Builders have launched OncoExplorer, a new cloud-based analytics portal that offers unprecedented decision-support capabilities to pharmaceutical companies.
Automation > IT & Software > News

PBR Supplier Recommendations

Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Delivery > Suppliers
CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL) specializes in GLP-compliant ELISPOT testing for pre-clinical and clinical trials involving the measurement/characterization of T cell responses in various species. ... Contract Research & Services > Clinical Trials > Suppliers
Polpharma - Generic Drug Manufacturer
Polpharma manufactures a wide range of prescription drugs and pharmaceuticals for in-patient care, used in cardiology, gastroenterology and neurology. We are among the top 20 generic drug manufacturers in the world with annual sales of one billion USD.... Suppliers
PCE - Pharma Vision Inspection
As the leading expert in Track & Trace solutions, Pharmacontrol Electronic GmbH (PCE) can draw on over 20 years' experience of supplying intelligent optical control systems for maximum process reliability in the pharmaceutical packaging industry.... Packaging > Suppliers
Valspar – valOR™ Barrier Additives for Plastics
Valspar successfully provides the pharmaceutical industry with products, such as coatings for aerosol cans and metal tubes that ensure products inside are free from contamination, making brands stay stronger, and products last longer.... Packaging > Suppliers
See more

PBR White Paper Recommendations

Introducing a Complexity Scoring System in Contract Negotiation By Cromsource
The great majority of clinical trial professionals will acknowledge that the start-up phase is the most challenging and important stage of any clinical trial. Indeed, recent publications also point to the critical nature of this phase of trial management, and specifically the importance of the process of contract and budget negotiation with sites.... Contract Research & Services > Contract Research > White Papers Microsoft Dynamics AX for Pharmaceutical Products and Services By Iperion
AX for pharma is a fully integrated ERP solution designed to meet the specific requirements for the pharmaceutical industry. At the basis is the Microsoft Dynamics AX 2012 software that allows companies of all sizes to manage their entire business processes, including supply chain, procurement, human resources, financials and projects.... Automation > IT & Software > White Papers Key Contact Details By GVK Biosciences Contract Research & Services > Contract Research > White Papers Contract Manufacturing By LABORATORIOS INIBSA
LABORATORIOS INIBSA is a pharmaceutical company with over 60 years of experience. We belong to the Group Inibsa. We provide products and services to group companies, such as Biotools, Keramat, Inibsa Portugal, Dental and Hospital, as well as other pharmaceutical companies through our contract manufacturing division.... Production & Manufacturing > Manufacturing > White Papers GxP Cloud Computing Brochure By Iperion
Iperion provides GxP cloud computing and private cloud infrastructure to the life sciences industry. Whether it concerns a single application or your complete IT infrastructure, we have the right solutions for your business needs. To software vendors who offer software as a service (SAAS) to the regulated industry, you have the choice to utilise our facilities in the form of infrastructure as a service (IAAS) or platform as a service (PAAS).... Automation > IT & Software > White Papers See more
1-15 of 48653 results